|
2022
|
Invention
|
Therapeutic agents for reducing parathyroid hormone levels.
Compounds having activity for loweri... |
|
|
Invention
|
Modifications of peptide compositions to increase stability and delivery efficiency.
The disclos... |
|
2017
|
Invention
|
Therapeutic agents for reducing parathyroid hormone levels. 7 subunits provides the desired activ... |
|
|
Invention
|
Calcimimetics and methods for their use.
Methods for treating subjects suffering from chronic ki... |
|
2016
|
Invention
|
Modifications of peptide compositions to increase stability and delivery efficiency. The disclose... |
|
2013
|
Invention
|
Compositions and methods for enhancing drug delivery across and into epithelial tissues.
This in... |
|
|
Invention
|
Pharmaceutical formulation.
A pharmaceutical formulation for a PKC modulatory peptide and a tran... |
|
|
Invention
|
Methods of use of epsilon inhibitor compounds for the attenuation of pain.
The disclosure herein... |
|
2012
|
Invention
|
Calcimimetics and methods for their use. Methods for treating subjects suffering from chronic kid... |
|
|
Invention
|
Compositions and methods for enhancing drug delivery across and into ocular tissues. This inventi... |
|
|
Invention
|
Therapeutic agents for regulating serum phosphorus. 7 subunits. The compound, when administered a... |
|
|
Invention
|
Therapeutic agents for regulating serum phosphorus. Methods for modulating serum phosphorus level... |
|
2011
|
Invention
|
Methods of use of epsilon inhibitor compounds for the attenuation of pain. The disclosure herein ... |
|
2010
|
Invention
|
Therapeutic agents for reducing parathyroid hormone levels. Compounds having activity for lowerin... |
|
|
Invention
|
Compositions and methods for enhancing drug delivery across and into epithelial tissues. This inv... |
|
|
Invention
|
Pharmaceutical formulation. A pharmaceutical formulation for a PKC modulatory peptide and a trans... |
|
|
Invention
|
Transdermal delivery of pkc modulatory peptides through microporated skin.
Disclosed herein are ... |
|
|
Invention
|
Transdermal delivery of pkc modulatory peptides through microporated skin. Disclosed herein are m... |
|
2009
|
Invention
|
Method of treating acute st-elevation myocardial infarction with a delta pkc antagonist.
Composi... |
|
2008
|
Invention
|
Protein kinase c-delta inhibitors that protect against cellular injury and inflammation and promo... |
|
|
Invention
|
Protein kinase c-d inhibitors that protect against cellular injury and inflammation and promote a... |
|
|
Invention
|
Protein kinase c-δ inhibitors that protect against cellular injury and inflammation and promote a... |
|
|
Invention
|
Methods of use of gamma inhibitor compounds for the attenuation of pain.
The disclosure herein r... |
|
|
Invention
|
Methods of use of gamma inhibitor compounds for the attenuation of pain. The disclosure herein re... |
|
|
Invention
|
Method of modifying peptide compositions. The present invention relates to a method of preparing ... |
|
2007
|
Invention
|
Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemi... |
|
2004
|
G/S
|
Pharmaceuticals, namely selective activators and inhibitors of protein kinase isozymes for the tr... |
